Article
Clinical Trial Recruitment: Who Are You Paying And What Are You Saying? – Clinical Leader
Clinical trial sponsors often struggle to recruit enough eligible patients, especially for rare diseases where the patient pool is small. Newer therapies, like cell and gene therapies, also face recruitment challenges due to the complex treatment processes. In the U.S., the Food and Drug Administration (FDA) has recognized the underrepresentation of certain demographic groups in clinical trials and advocates for broader eligibility criteria and reducing burdens related to study participation. These challenges require sponsors to consider various recruitment strategies.
In an article in Clinical Leader, Michelle Axelrod and Noah Goldstein discuss practical compliance considerations related to payments to healthcare professionals and patients in connection with recruitment, as well as patient recruitment communications.
